{
  "basic_data": [
    {
      "frozen": "True",
      "cell_type": "hiPSC",
      "cell_line_alt_name": "UBC3 M1",
      "hpscreg_name": "CIAU1002-C"
    }
  ],
  "generator": [
    {
      "group": "Centenary Institute of Cancer Medicine and Cell Biology"
    }
  ],
  "contact": [
    {
      "name_initials": "C",
      "group": "Centenary Institute of Cancer Medicine and Cell Biology",
      "e_mail": "c.semsarian@centenary.org.au",
      "last_name": "Semsarian",
      "first_name": "Christopher"
    }
  ],
  "publications": [
    {
      "doi": "10.1016/j.scr.2023.103153",
      "title": "Generation of an induced pluripotent stem cell line from a patient with conduction disease and recurrent ventricular fibrillation with a sodium voltage-gated channel alpha subunit 5 (SCN5A) gene c.392 + 3A > G splice-site variant",
      "journal": "Stem Cell Research",
      "last_author": "Christopher Semsarian",
      "first_author": "Serena Li",
      "year": "2023.0"
    }
  ],
  "donor": [
    {
      "sex": "Female",
      "age": "A30_34",
      "disease_description": "Patient with recurrent ventricular fibrillation, conduction disease, and non-ischemic cardiomyopathy carrying a heterozygous SCN5A c.392 + 3A > G variant",
      "disease_name": "Left bundle branch block; recurrent ventricular fibrillation; conduction disease; non-ischemic cardiomyopathy"
    }
  ],
  "genomic_modifications": [
    {
      "cytoband": "3p22.2",
      "genotype": "Heterozygous SCN5A c.392 + 3A > G",
      "mutation_type": "Variant",
      "loci_name": "SCN5A",
      "description": "Heterozygous SCN5A c.392 + 3A > G splice-site variant"
    }
  ],
  "differentiation_results": [
    {
      "marker_list": "SOX17; CXCR4",
      "method_used": "Immunostaining",
      "show_potency": "True",
      "cell_type": "Endoderm",
      "description": "In vitro directed differentiation"
    },
    {
      "marker_list": "NKX2.5; TNNT2",
      "method_used": "Immunostaining",
      "show_potency": "True",
      "cell_type": "Mesoderm",
      "description": "In vitro directed differentiation"
    },
    {
      "marker_list": "PAX6; NESTIN",
      "method_used": "Immunostaining",
      "show_potency": "True",
      "cell_type": "Ectoderm",
      "description": "In vitro directed differentiation"
    }
  ],
  "undifferentiated_characterisation": [
    {
      "epi_pluri_score": "Missing",
      "pluri_test_score": "Missing",
      "pluri_novelty_score": "Missing"
    }
  ],
  "genomic_characterisation": [
    {
      "karyotype": "46,XX",
      "karyotype_method": "Whole genome sequencing",
      "summary": "Normal female karyotype with no aneuploidies was confirmed at passage 18.",
      "passage_number": "18"
    }
  ],
  "induced_derivation": [
    {
      "i_source_cell_type_term": "peripheral blood mononuclear cell",
      "non_int_vector": "Episomal",
      "derivation_year": "2021",
      "non_int_vector_name": "Epi5 Episomal iPSC Reprogramming Kit (Thermo Fisher, MA, USA)",
      "i_source_cell_origin_term": "blood"
    }
  ],
  "embryonic_derivation": [
    {
      "embryo_stage": "Missing",
      "zp_removal_technique": "Missing",
      "trophectoderm_morphology": "Missing",
      "icm_morphology": "Missing",
      "e_preimplant_genetic_diagnosis": "Missing"
    }
  ],
  "ethics": [
    {
      "ethics_number": "X19-0108",
      "institutional_HREC": "Sydney Local Health District"
    },
    {
      "ethics_number": "2019/ETH00461",
      "institutional_HREC": "Sydney Local Health District"
    }
  ],
  "culture_medium": [
    {
      "co2_concentration": "0.05",
      "o2_concentration": "0.21",
      "passage_method": "Enzymatically"
    }
  ]
}